日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Outcomes of bispecific antibodies after CAR T-cell failure for large B-cell lymphoma: results from the ABC consortium

CAR-T细胞疗法治疗大B细胞淋巴瘤失败后双特异性抗体的疗效:来自ABC联盟的研究结果

Melody, Megan; Grover, Natalie; Franco, Stephanie; Romancik, Jason; Cortese, Matthew; Moyo, Tamara K; Bhansali, Rahul S; Ollila, Thomas; Kenkre, Vaishalee; Fitzgerald, Lindsey; Hess, Brian; Matasar, Matt; Shouse, Geoffrey; Annunzio, Kaitlin; Herr, Megan M; Davis, James A; Jesme, Christy; Pelcovits, Ari; Moreira, Jonathan; Ma, Shuo; Winter, Jane N; Lin, Adam; Danilov, Alexey; Roy, Ishan; Barta, Stefan K; Gordon, Leo I; Stephens, Deborah; Cohen, Jonathon B; Epperla, Narendranath; Karmali, Reem

Outcomes for CART as 2L vs 3L vs 4L or beyond in aggressive B-cell lymphoma: real-world evidence from the ABC Consortium

CAR-T方案作为侵袭性B细胞淋巴瘤二线、三线、四线及以上治疗的疗效:来自ABC联盟的真实世界证据

Wang, John S; Ellsworth, Brandon L; Melody, Megan; Epperla, Narendranath; Stephens, Deborah; Romancik, Jason; Cortese, Matthew; Bhansali, Rahul; Moyo, Tamara K; Kenkre, Vaishalee; Ollila, Thomas; Hess, Brian; Fitzgerald, Lindsey; Shouse, Geoffrey; Matasar, Matthew; Herr, Megan M; Davis, James; Jesme, Christy; Pelcovits, Ari R; Moreira, Jonathan; Lin, Adam Y; Ma, Shuo; Winter, Jane N; Danilov, Alexey V; Shah, Nirav N; Barta, Stefan K; Cohen, Jonathon B; Gordon, Leo I; Grover, Natalie; Karmali, Reem

Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy

双重打击和双重表达淋巴瘤:CD19靶向CAR T细胞疗法生存结果的多中心分析

Karmali, Reem; Shouse, Geoffrey; Torka, Pallawi; Moyo, Tamara K; Romancik, Jason; Barta, Stefan K; Bhansali, Rahul; Cohen, Jonathon B; Shah, Nirav N; Zurko, Joanna; Kenkre, Vaishalee P; Hess, Brian; Stephens, Deborah M; Fitzgerald, Lindsey; Ollila, Thomas; Tabiti, Bukky; Roy, Ishan; Ma, Shuo; Winter, Jane; Pro, Barbara; Moreira, Jonathan; Danilov, Alexey V; David, Kevin; Gordon, Leo I; Epperla, Narendranath

Real World Outcomes of Patients with Aggressive Lymphoma and Autoimmune Disease Treated with CART

CAR-T细胞疗法治疗侵袭性淋巴瘤合并自身免疫性疾病患者的真实世界疗效

Altomare, Nicole J; Herr, Megan M; Nair, Nisha M; Stephens, Deborah M; Cohen, Jonathon B; Epperla, Narendranath; Cortese, Matthew; Bhansali, Rahul; Moyo, Tamara K; Kenkre, Vaishalee; Ollila, Thomas; Hess, Brian; Fitzgerald, Lindsey; Shouse, Geoffrey; Davis, James A; Jesme, Christy; Pelcovits, Ari; Moreira, Jonathan; Lin, Adam; Ma, Shuo; Winter, Jane N; Danilov, Alexey; Barta, Stefan K; Gordon, Leo I; Romancik, Jason; Grover, Natalie S; Karmali, Reem

Measurable Residual Disease Testing Following Nonintensive Chemoimmunotherapy is Predictive of Need for Maintenance Therapy in Previously Untreated Mantle Cell Lymphoma: A Wisconsin Oncology Network Study

非强化化疗免疫疗法后可测量的残留病灶检测结果可预测既往未接受治疗的套细胞淋巴瘤患者是否需要维持治疗:威斯康星肿瘤网络研究

Chang, Julie E; McQuinn, Danielle; Hyun, Meredith; Kim, KyungMann; Kenkre, Vaishalee P; Rajguru, Saurabh A; Pophali, Priyanka A; Endres, Mariah; Howard, Mitch; Wassenaar, Tim; Warren, Ruth Callaway; Mattison, Ryan J; Wisinski, Kari B; Fletcher, Christopher D

An Insight into Clinicopathological Parameters and Prognostic Significance of Double Expressor Diffuse Large B-Cell Lymphoma in a Tertiary Care Center

三级医疗中心双表达弥漫性大B细胞淋巴瘤的临床病理参数及预后意义分析

Lakshminarayanan, Ramya; Priyathersini, Nagarajan; Shanmugam, Sri Gayathri; Mohanendran, Arthi; Moganavalli Giridhar, Viha Vaishalee

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma

JAK抑制剂可增强霍奇金淋巴瘤患者的免疫检查点阻断疗法。

Jaroslav Zak ,Isaraphorn Pratumchai ,Brett S Marro ,Kristi L Marquardt ,Reza Beheshti Zavareh ,Luke L Lairson ,Michael B A Oldstone ,Judith A Varner ,Livia Hegerova ,Qing Cao ,Umar Farooq ,Vaishalee P Kenkre ,Veronika Bachanova # ,John R Teijaro #

Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission

自体移植与CAR-T疗法在弥漫性大B细胞淋巴瘤完全缓解期患者中的比较

Shadman, Mazyar; Ahn, Kwang W; Kaur, Manmeet; Lekakis, Lazaros; Beitinjaneh, Amer; Iqbal, Madiha; Ahmed, Nausheen; Hill, Brian; Hossain, Nasheed M; Riedell, Peter; Gopal, Ajay K; Grover, Natalie; Frigault, Matthew; Brammer, Jonathan; Ghosh, Nilanjan; Merryman, Reid; Lazaryan, Aleksandr; Ram, Ron; Hertzberg, Mark; Savani, Bipin; Awan, Farrukh; Khimani, Farhad; Ahmed, Sairah; Kenkre, Vaishalee P; Ulrickson, Matthew; Shah, Nirav; Kharfan-Dabaja, Mohamed A; Herrera, Alex; Sauter, Craig; Hamadani, Mehdi

Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy

既往接受过抗CD19 CAR T细胞疗法治疗的患者发生后续恶性肿瘤

Melody, Megan; Epperla, Narendranath; Shouse, Geoffrey; Romancik, Jason; Allen, Pamela; Moyo, Tamara K; Kenkre, Vaishalee; Ollila, Thomas; Fitzgerald, Lindsey; Hess, Brian; David, Kevin; Herr, Megan M; Odetola, Oluwatobi; Lin, Adam; Moreira, Jonathan; Ma, Shuo; Winter, Jane N; Roy, Ishan; Stephens, Deborah; Danilov, Alexey; Shah, Nirav N; Barta, Stefan K; Cortese, Matthew; Cohen, Jonathon B; Gordon, Leo I; Karmali, Reem

Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy

种族和社会健康决定因素对接受 CAR-T 疗法治疗的侵袭性 B 细胞非霍奇金淋巴瘤患者预后的影响

Karmali, Reem; Machhi, Rushad; Epperla, Narendranath; Shouse, Geoffrey; Romancik, Jason; Moyo, Tamara K; Kenkre, Vaishalee; Ollila, Thomas A; Fitzgerald, Lindsey; Hess, Brian; David, Kevin; Roy, Ishan; Zurko, Joanna; Chowdhury, Sayan Mullick; Annunzio, Kaitlin; Ferdman, Robert; Bhansali, Rahul S; Harris, Elyse I; Liu, Jieqi; Nizamuddin, Imran; Ma, Shuo; Moreira, Jonathan; Winter, Jane; Pro, Barbara; Stephens, Deborah M; Danilov, Alexey; Shah, Nirav N; Cohen, Jonathon B; Barta, Stefan K; Torka, Pallawi; Gordon, Leo I